GLP-1 S 10mg
US$ 28.16
glp 1 drug classification GLP-1 Medications: Everything You Need to Know Market Overview: GLP-1 Agonists and
Description
Overall, semaglutide was associated with improved glycaemic control, when used either as monotherapy or as add-on therapy in patients with T2DM against both placebo and active comparators (including other GLP-1 RAs)
This GLP-1 drug also reduces the risk of heart attack and stroke in people with diabetes and cardiovascular disease
Bragga, Qin)
Retrieved from Eli Lilly and Company-b
Weight loss is not a side effect but the primary endpoint
Potential side effects Reported side effects in studies have been similar to other weight loss injections
